Breakthrough Biologics: The Science and Economics of Personalized Immunotherapy Treatment Costs
Personalized immunotherapies like CAR-T cell therapy are transforming oncology, achieving remarkable remission rates for previously untreatable cancers. We analyze the complex molecular science, the logistical challenges of autologous cell manufacturing, and the economic strategies used to fund these high-value treatments.
Read full article →




























